Rigel Pharmaceuticals (RIGL) Raw Materials (2021 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Raw Materials of $3.4 million for Q1 2026, up 218.2% year-over-year from $1.1 million in Q1 2025, and down 24.08% quarter-over-quarter from $4.5 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Raw Materials (2021 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Raw Materials history runs 6 years deep, the most recent figure standing at $3.4 million for Q1 2026.
- In Q1 2026, Raw Materials rose 218.2% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (up 218.2% YoY), while the FY2025 annual figure was $4.5 million, up 319.13% from the prior year.
- Raw Materials for Q1 2026 stood at $3.4 million, down from $4.5 million in the prior quarter.
- The five-year high for Raw Materials was $9.6 million in Q2 2025, with the low at $1.1 million in Q4 2024.
- The 5-year median for Raw Materials is $4.6 million (2022), against an average of $4.4 million.
- The sharpest annual moves came in 2024 and 2025: Raw Materials slumped 76.63% in 2024, then jumped 348.76% in 2025.
- Rigel Pharmaceuticals' Raw Materials stood at $4.6 million in 2022, then advanced by 1.19% to $4.6 million in 2023, then plunged by 76.63% to $1.1 million in 2024, then jumped by 319.13% to $4.5 million in 2025, then slipped by 24.08% to $3.4 million in 2026.
- Business Quant data shows RIGL's Raw Materials at $3.4 million in Q1 2026, $4.5 million in Q4 2025, and $7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.23 Mn |
| Mar 31, 2026 | 3.43 Mn |
| Dec 31, 2025 | 4.51 Mn |
| Sep 30, 2025 | 6.95 Mn |
| Jun 30, 2025 | 9.63 Mn |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 3.92 Mn |
| Dec 31, 2023 | 4.61 Mn |
| Jun 30, 2023 | 6.88 Mn |
| Mar 31, 2023 | 6.91 Mn |
| Dec 31, 2022 | 4.56 Mn |
| Sep 30, 2022 | 4.56 Mn |
| Jun 30, 2022 | 4.56 Mn |
| Mar 31, 2022 | 4.56 Mn |
| Dec 31, 2021 | 5.14 Mn |
| Sep 30, 2021 | 5.14 Mn |
| Jun 30, 2021 | 5.14 Mn |